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Introduction {#s1}
============

Approximately 35% of individual differences in human longevity are estimated to be heritable [@pone.0115616-Crimmins1]. The science of aging has made tremendous strides since the discovery in the 1980s that specific gene mutations in yeast, worms and flies can extend lifespan [@pone.0115616-Engelfriet1]. However, extrapolation of these findings to the complex human body remains a major challenge due to differences in physiology and aging-related diseases. Nevertheless, animal models have provided key insights to candidate genes and pathways that provide a focus for investigations in humans. Included among these are the family of nicotinamide adenine dinucleotide (NAD) dependent protein deacetylases, including the Sirtuins [@pone.0115616-Guarente1]. Initial experiments within *Caenorhabditis elegans* indicated a duplication containing *sir-2.1*, the gene most homologous to yeast *SIR2*, increased lifespan by 50% [@pone.0115616-Tissenbaum1]. However, subsequent studies suggested a second mutation within the *dyf* gene was responsible for the majority of the increase in lifespan [@pone.0115616-Burnett1]. When controlling for the second mutation, the effect of *sir-2.1* on lifespan was reduced from a 50% increase to a 10--15% increase.

Sirtuins have also been linked to oxidative stress through genetic manipulation of Sir2 in eukaryotic model organisms [@pone.0115616-Merksamer1]. Calorie restriction has been suggested to slow aging by reducing levels of reactive oxygen species. Lifespan extension observed during calorie restriction in yeast was not seen in strains mutant for Sir2, suggesting increased lifespan induced by calorie restriction requires the activation of the Sir2 protein [@pone.0115616-Lin1].

Mammals have seven sirtuin genes (*SIRT1-7*) comprising the sirtuin family of proteins (SIRT1-7). The proteins vary in tissue specificity, subcellular localization, enzymatic activity and targets [@pone.0115616-Houtkooper1]. SIRT1, SIRT6 and SIRT7 are found in the nucleus, SIRT2 is found in the cytoplasm, and SIRT3, SIRT4 and SIRT5 are primarily found in the mitochondria. *SIRT1*, *2* and *3* have been shown to control the oxidative stress response by regulating the FOXO family of Forkhead transcription factors and elevating downstream targets such as manganese superoxide dismutase (MnSOD or SOD2) [@pone.0115616-Brunet1]--[@pone.0115616-Zhang1]. *SIRT1* has also been demonstrated to mediate the p53 regulatory pathway, decreasing the sensitivity of cells to DNA damage and oxidative stress [@pone.0115616-Luo1]. Although not proven, a causal role for oxidative stress in aging remains one of the most widely accepted aging theories [@pone.0115616-Merksamer1].

In addition to being downstream targets of sirtuins, variants in *FOXO1*, *FOXO3* and *p53* have shown independent associations with human lifespan [@pone.0115616-Zeng1]--[@pone.0115616-Orsted1]. *CAMKIV* has been shown to be associated with lifespan through activation of survival proteins AKT1, SIRT1 and FOXO3A [@pone.0115616-Malovini1].

The variability in individual lifespan, not attributed to genetic variation, and changes in life expectancy over the past century have largely been attributed to environmental factors including smoking, body mass index and alcohol consumption [@pone.0115616-Newman1]. The importance of investigating the impact of genetic variation on lifespan while controlling for these environmental factors and disease occurrence is pivotal. The aim of this study was to evaluate the association of sirtuin single nucleotide polymorphisms (SNPs) with age at death while controlling for aging-related risk factors, including gender, body mass index, exercise, comorbidities, smoking and alcohol consumption. Additional gene variants located within candidate oxidative stress genes and genes shown to interact with the sirtuin family of genes were also evaluated.

Methods {#s2}
=======

Study Population {#s2a}
----------------

The Established Population for Epidemiologic Studies of the Elderly (EPESE) project was initiated by the intramural Epidemiology, Demography and Biometry Program of the National Institute on Aging in 1980. This study has been described in detail [@pone.0115616-CornoniHuntley1]. Four populations were included in the project; the Iowa population was the focus of this analysis. The Iowa component of EPESE "Iowa 65+ Rural Health Study" (65+RHS) targeted residents living in two Iowa counties, Washington and Iowa, aged 65 and older as of September 1, 1981. Approximately 4600 persons who were 65 years and older were contacted and 80% agreed to participate, resulting in an initial cohort of 3673. Upon obtaining consent, the 65+RHS baseline survey was completed in the participant\'s home during 1982--83, with seven follow-up interviews through 1992 [@pone.0115616-CornoniHuntley1]. The baseline, third and sixth follow-up surveys were conducted in the participant\'s home by a trained interviewer [@pone.0115616-Cerhan1]. At the sixth follow-up interview, during 1987--89, 1940 of 2739 participants agreed to provide a blood sample (71% of those re-interviewed). Blood was drawn and then frozen at −70°C until thawed for assay. Only 1260 of the 1940 blood specimens were available for this study. Participants whose blood was not analyzed included those who chose not to donate blood (n = 799), missing samples (n = 680), and samples that did not have a genotype call rate ≥90% (n = 68). This project was reviewed and approved by the University of Iowa IRB. Participant information was anonymized prior to analysis.

Ascertainment of Death {#s2b}
----------------------

Death dates for nearly all participants were provided through the National Death Index in a linkage completed in 2009 [@pone.0115616-Dutta1]. No death date was identified for approximately 120 of the cohort members at the time of the linkage. For these 120, a linkage with the State Health Registry of Iowa (SHRI) death certificate database in April, 2012 and a search of the Social Security Death Index in April, 2013 were used in efforts to obtain date of death. Death dates for all but 17 participants who donated blood were found. For these participants date of last known contact was used for age at death.

Aging-Related Risk Factor Data Collection {#s2c}
-----------------------------------------

Aging-related risk factors were not of direct interest in the analysis reported herein and were only included to control for confounding. Information collected in the baseline survey on demographic and lifestyle characteristics in the 65+RHS included smoking, alcohol consumption and physical activity. Several participants either refused or did not supply these data. To include all participants in the analysis an unknown category was created for missing data. To ensure the unknown category was not directly impacting results, sensitivity analyses excluding unknowns were conducted to ensure the general magnitude and direction of association was similar.

Participants were categorized as ever vs. never smokers. Ever smokers included cigarette, pipe, cigar and occasional smokers. These were grouped since the subgroups were too small to have sufficient power for an association analysis. For alcohol consumption, participants were classified as never, former, current low or current high. Collapsed categorical variables were not considered for alcohol consumption due to abstinence and high consumption having an elevated mortality risk relative to moderate consumption. An average of 1 drink per day for females and 2 drinks per day for males was used to distinguish between current low and current high alcohol consumption [@pone.0115616-Roerecke1]. Self-reported height and weight were used to calculate body mass index (BMI) and categorized according to the World Health Organization\'s definitions [@pone.0115616-Tremblay1]. Participants were asked about exercise and daily tasks to assess physical activity. Responses were used to classify participants as inactive, moderately active or highly active based on two previously published EPESE reports [@pone.0115616-Cerhan1], [@pone.0115616-Simonsick1]. Previous EPESE analyses utilized the health history portion of the baseline survey to create a comorbidity score [@pone.0115616-Fillenbaum1]. Participants were asked if a doctor had ever told them they had the following conditions: myocardial infarction, stroke, diabetes, cancer or hypertension and were categorized as having 0, 1 or\>1 comorbidities for analysis.

SNP Selection and Genotyping {#s2d}
----------------------------

The International HapMap Project was utilized to download SNP genotype data based on Utah samples. Of the genotyped populations available through HapMap, the Northern and Western Europe (CEU) population was most similar in ancestral origin to the 65+RHS. DNA from select CEU individuals also served as controls during genotyping.

SNP genotype data were downloaded for the following genes: *SIRT1, SIRT2, SIRT3, SIRT4, SIRT5, SIRT6, SIRT7, AKT1, CAMK4, FOXO1, FOXO3, GPX1, SOD2, SOD3* and *TP53*. This information was uploaded into Haploview 4.2 using a specified minor allele frequency of 0.05. For *SIRT1, 2, 3* and *6* the tagger configuration was forced to include all SNPs reported in the literature and used to determine which additional SNPs were needed for entire gene coverage. For *SIRT4, 5* and *7*, as well as the other candidate genes, a literature search was conducted to identify SNPs associated with aging and other diseases. If no literature was found, Haploview was used to select the SNP(s) that tagged for the highest number of additional SNPs.

Entire gene coverage, as determined by Haploview 4.2, was met for *SIRT1* and *SIRT6*. For *SIRT3* no assay for one of the selected SNPs, rs12222188, was available through TaqMan. Even with this SNP excluded, 97% of the genetic information was captured by the other 12 SNPs that were identified.

Genotyping was performed on 1260 individuals at 48 known SNPs using Fluidigm 192.24 Dynamic Array integrated fluid circuits (Fluidigm Incorporated, San Francisco, CA). Samples and Taqman SNP genotyping assays (Life Technologies, Grand Island, NY) were loaded into reaction chambers by the IFC Controller RX and a fast PCR protocol was run on the FC1 Cycler. The chip was read using fluorescence detection by the BioMark HD Reader and the Fluidigm analysis software v3.1.2 was used to view and interpret results. All genotype data were uploaded to the database Progeny 8, which detects and flags all genotyping discrepancies. All samples with a call rate of ≤90% were excluded from analyses (n = 68).

Statistical Analysis {#s2e}
--------------------

Participants of the Iowa 65+RHS study are representative of an elderly Iowa, Caucasian population [@pone.0115616-CornoniHuntley1]. Student\'s t-tests and Pearson\'s chi-square tests were used to compare covariate distributions between participants whose blood was analyzed *versus* those without a blood sample. The baseline interview was used to capture covariates for all participants.

Agreement of observed genotype frequencies with expected Hardy-Weinberg equilibrium frequencies was assessed. Linkage disequilibrium (LD) was assessed between all SNP pairs using the correlation coefficient, r^2^. SNP pairs with an r^2^ of ≥0.8 were considered to be in high LD; pairs with an r^2^ of 0.5--0.8 were considered to be in moderate LD. The Kruskal-Wallis test was used to evaluate SNP-covariate associations.

Multivariable linear regression analysis was used to assess SNP-age at death associations while controlling for aging-related factors. A base model was constructed to determine which variables were significantly associated with age at death prior to the inclusion of genotype data. Variables considered were gender, smoking status, alcohol consumption, body mass index (BMI) category, comorbidity count, exercise classification and all two-way interaction effects. Based on the corrected Akaike Information Criterion (AICc) in backward selection, components of the pre-genotype base model included: gender, comorbidity count, smoking, alcohol consumption, BMI and the BMI x smoking interaction effect. Exercise was not significant in the base model and therefore was not included in any subsequent analyses.

To assess the impact of each genetic variant on age at death a co-dominant genetic model was assumed [@pone.0115616-Lettre1] and each SNP in turn was added to the base model. Partial correlation coefficients were calculated to estimate the strength of the linear relationship between mean age at death and each SNP while controlling for the effects of the other variables. Given the evidence for effect modification due to gender within animal models [@pone.0115616-Kanfi1] a SNP × gender interaction effect was also tested. Because this interaction effect was not included in base model selection, an associated p-value of ≤0.10 was used to determine inclusion of this interaction effect. For 45 of the 48 SNPs evaluated, this interaction effect was not significant. For these SNPs, positive false discovery rates (pFDR) and *q-*values were computed to control for multiple testing [@pone.0115616-Storey1]. For the three SNPs where the SNP × gender interaction effect was significant, follow-up gender-specific analysis was conducted. Gender-specific analysis of risk factor frequency was completed. All statistical tests were performed using SAS v9.3 (SAS Institute Inc., Cary, NC).

Results {#s3}
=======

Participant characteristics and environmental risk factors {#s3a}
----------------------------------------------------------

Of the 3763 participants in 65+RHS, 1192 had genotype information for the 48 SNPs within 15 candidate genes at a sufficient call rate (\>90%) for analysis. There are some expected differences between participants included in this analysis and the remaining Iowa 65+RHS cohort. As shown in [Table 1](#pone-0115616-t001){ref-type="table"}, the 1192 participants in this study had a higher mean age at death, smoked less at baseline, had slightly higher baseline BMI, and lower comorbidity at baseline. Participants had to survive to the 6^th^ interview to consent to submit a blood sample, resulting in a higher mean age at death. This was also consistent with less smoking and lower comorbidity in participants whose blood was analyzed, indicating a historically healthier lifestyle. The higher BMI in participants analyzed could be due to a significant difference in the proportion of ever smokers, 28 vs. 35% (p = 0.01).

10.1371/journal.pone.0115616.t001

###### Characteristics of 65+ RHS participants by genotyping status.

![](pone.0115616.t001){#pone-0115616-t001-1}

                                       Participants Not Genotyped (n = 2481)   Participants Genotyped (n = 1192)          
  -------------------- -------------- --------------------------------------- ----------------------------------- ------- -------------
  Age at Death              Mean                       86.33                                 89.46                        
                          p-value                                                         **p\<0.01**                     
                           Range                      66--109                               72--107                       
                          Missing                       50                                    17                          
  **Characteristic**    **Category**                   **N**                                **(%)**                **N**     **(%)**
  Smoking                    No                        1790                                  72.1                   892       74.8
                            Yes                         691                                  27.9                   300       25.2
                          p-value                                                                                           p = 0.08
  Drinking Status          Never                        886                                  46.6                   487       48.9
                           Former                       194                                  10.2                   91         9.1
                        Low Current                     750                                  39.4                   386       38.8
                        High Current                    72                                    3.8                   32         3.2
                          p-value                                                                                           p = 0.54
                          Missing                       579                                                         196   
  Body Mass Index       Underweight                     109                                   5.4                   29         2.7
                           Normal                       990                                  48.9                   482       44.4
                         Overweight                     698                                  34.4                   440       40.6
                           Obese                        230                                  11.3                   134       12.3
                          p-value                                                                                          **p\<0.01**
                          Missing                       454                                                         107   
  Comorbidity Count          0                          999                                  40.5                   551       46.5
                             1                         1077                                  43.7                   502       42.4
                            \>1                         389                                  15.8                   131       11.1
                          p-value                                                                                          **p\<0.01**
                          Missing                       16                                                           8    

Comparison of covariables included in the multivariable model between 65+RHS participants with genotype data compared to the rest of the Iowa cohort. These covariables, collected during the baseline interview, were selected because they are aging-related risk factors, and were included in the model to control for confounding. The Iowa 65+RHS cohort is representative of an elderly Iowa, Caucasian population. Expected differences in age (due to blood withdraw at follow-up interview six) and factors historically related to a healthier lifestyle were seen between those genotyped and those not genotyped.

Association of Minor Allele Homozygotes with Decreased Lifespan {#s3b}
---------------------------------------------------------------

Homozygous minor allele genotypes within rs2841505 (*SIRT5)*, rs107251 *(SIRT6)*, and rs2536512 *(SOD3)* were associated with a shorter lifespan ([Table 2](#pone-0115616-t002){ref-type="table"}) after controlling for aging-related risk factors (gender, BMI, smoking, alcohol consumption and comorbidity). rs107251 (*SIRT6)* showed the greatest impact on lifespan, the ten cohort members homozygous for the minor T allele had a decreased lifespan compared to those with the CT or the CC genotypes (5.9 and 5.5 years, respectively). As shown in [Fig. 1](#pone-0115616-g001){ref-type="fig"}, there was a significant difference in the genotype distributions at this locus between the 65+RHS cohort and the HapMap-CEU population (p\<0.01), with an obvious deficit of TT homozygotes in the 65+RHS cohort. The crude association for this SNP was of a similar magnitude; the TT genotype had a mean lifespan of 82.1 years, where CT genotype was 88.0 and CC genotype was also 87.6.

![*AKT1* rs3803304 location and adjusted mean age at death and genotype frequency distribution stratified by gender.\
A. *SIRT6* is located on chromosome 19p13.3, 8491 bp in length with 8 exons [@pone.0115616-Kent1]. rs107251, indicated by a blue dash and blue arrows, is an intron variant located after exon 4. It is not located in a mammalian conserved region indicating it is not likely a causal variant for lifespan. Several SNPs are located in *SIRT6*; rs107251 is thought to capture all of this information. SNPs denoted by a red dash are missense variants; a green dash denotes a synonymous variant. B. CC genotypes and CT genotypes have a \>5-year adjusted mean survival advantage over the TT genotype. Data were calculated by multivariable linear regression with adjustment for BMI, smoking, alcohol consumption and comorbidities. There is a significant genotype distribution difference between the 65+RHS and HapMap-CEU populations (p\<0.01).](pone.0115616.g001){#pone-0115616-g001}

10.1371/journal.pone.0115616.t002

###### Genotype frequency, distribution, and genotype-specific mean age at death of the SNPs associated with lifespan.

![](pone.0115616.t002){#pone-0115616-t002-2}

  Gene       Chromosome     rs\#      Position    Genotype   Genotype frequency   Age at death    q-value    Partial correlation[\*](#nt102){ref-type="table-fn"}
  --------- ------------ ----------- ----------- ---------- -------------------- -------------- ----------- ------------------------------------------------------
  *SIRT3*     11p15.5     rs511744     209089        CC             591               87.2       **0.046**                          0.0053
                                                     CT             494               88.0                  
                                                     TT             106               88.5                  
                                                  Missing            1                                      
  *SIRT5*       6p23      rs2841505   13679574       TT             534               88.1       **0.043**                          0.0053
                                                     TG             539               87.3                  
                                                     GG             119               86.8                  
                                                  Missing                                                   
  *SIRT6*     19p13.3     rs107251     4127085       CC             940               87.6       **0.012**                          0.0075
                                                     CT             239               88.0                  
                                                     TT              10               82.1                  
                                                  Missing            3                                      
  *SOD3*       4p15.2     rs2536512   24801315       GG             483               88.9       **0.048**                          0.0057
                                                     GA             466               87.8                  
                                                     AA             124               87.4                  
                                                  Missing           119                                     
  *FOXO3*       6q21      rs4946935   109000742      GG             540               87.3       **0.042**                          0.0058
                                                     GA             469               87.7                  
                                                     AA             111               88.9                  
                                                  Missing            72                                     

\*The partial correlation is a measure of the strength of the relationship between the SNP and mean age at death after controlling for gender, comorbidity count, smoking, alcohol consumption, BMI and the BMI × smoking interaction effect.

Of the 45 SNPs where the SNP × gender interaction effect was not significant, *SIRT3*, *5*, *6*, *FOXO3* and *SOD3* SNPs were associated with age at death. All SNPs gene, rs number, chromosome, chromosome position, genotype frequency, age at death, q-value and partial correlation are given.

Cohort members with the rs2841505 (*SIRT5*) GG genotype had decreased lifespan compared to those with the TG or the TT genotype (0.5 and 1.3 years, respectively). Cohort members with the rs2536512 (*SOD3*) AA genotype had decreased lifespan compared to those with the GA genotype or the GG genotype (0.4 and 1.5 years, respectively).

The remaining SNPs within *SIRT5* and *SOD3* and candidate SNPs within *SIRT1-3*, *GPX1*, *FOXO1*, *SOD2*, and *CAMK4* showed no association between the homozygous minor allele genotype and decreased lifespan ([S1 Table](#pone.0115616.s001){ref-type="supplementary-material"}).

Association of Minor Allele Homozygotes with Increased Lifespan {#s3c}
---------------------------------------------------------------

Homozygous minor allele genotypes within rs511744 (*SIRT3)* and rs4946935 (*FOXO3)* were associated with an increased lifespan. Cohort members with the rs511744 (*SIRT3)* TT genotype had an increased lifespan compared to those with the CT or the CC genotype (0.5 and 1.3 years, respectively). Cohort members with the rs4946935 (*FOXO3)* AA genotype had an increased lifespan compared to those with the GA or the GG genotype (1.2 and 1.6 years, respectively).

The remaining SNPs within *SIRT3* and *FOXO3* and candidate SNPs within *SIRT1*, *SIRT2*, *SIRT4*, *FOXO1*, and *TP53* showed no association between the homozygous minor allele genotype and increased lifespan ([S1 Table](#pone.0115616.s001){ref-type="supplementary-material"}).

Gender Effect Modification of the Association between Candidate Genetic Variants and Lifespan {#s3d}
---------------------------------------------------------------------------------------------

Gender modified the association between three SNPs (rs4758633 (*SIRT3)*, rs4712047 (*SIRT5*) and rs3803304 (*AKT1*)) and lifespan (p\<0.1). In [Fig. 2](#pone-0115616-g002){ref-type="fig"}, females with the rs4758633 AA genotype had an increased lifespan compared to females with the GA (0.7 years) or the GG genotype (1.8 years), whereas males with the AA genotype had a decreased lifespan of 0.7 years compared to males with the GA genotype but an increased lifespan of 0.3 years when compared to males with the GG genotype. In [Fig. 3](#pone-0115616-g003){ref-type="fig"}, females with the rs4712047 (*SIRT5*) GG genotype had an increased lifespan compared to females with the GA or the AA genotype (0.9 and 1.5 years, respectively), whereas males with GG genotype had a decreased lifespan compared to males with the GA or the AA genotype (0.5 and 1.7 years, respectively). In [Fig. 4](#pone-0115616-g004){ref-type="fig"}, females with the rs3803304 (*AKT1)* CC genotype had an increased lifespan compared to females with the GC or the GG genotype (1.8 and 2.2 years, respectively) whereas males with CC genotype had a decreased lifespan compared to males with the GC or the GG genotype (2.1 and 1.0 years, respectively). Risk factor distribution differed between males and females ([Fig. 3](#pone-0115616-g003){ref-type="fig"}).

![*SIRT3* from chromosomal to base pair level demonstrating the location and characteristics of the two *SIRT3* SNPs significantly associated with adjusted mean age at death.\
A. *SIRT3* is located on chromosome 11p15.5, 21332 bp in length with 5 exons.[@pone.0115616-Kent1] Of 12 *SIRT3* SNPs genotyped, two were significantly associated with age at death, rs511744 and rs4758633, denoted by the blue arrows. These two SNPs are approximately 450 base pairs apart, located just after exon 1. Even though very close in physical location, there was a significant gender × rs4758633 interaction effect (p = 0.08) but not rs511744 (p = 0.49). These two SNPs are not in mammalian conserved regions (MCR) indicating they are likely not causal but in LD with the functional variant. SNPs denoted by a red dash are missense variants; a green dash denotes a synonymous variant. B. Adjusted mean age at death for males and females for rs511744. Data were calculated by multivariable linear regression with adjustment for BMI, smoking, alcohol consumption and comorbidities. Genotype frequency distribution did not differ between males and females for rs511744 (p = 0.86) C. Adjusted mean age at death for males and females for rs4758633. Genotype frequency distribution did differ for rs4758633 (p\<0.01).D. rs511744 and rs4758633 are in moderate LD (r^2^ value between 0.5-0.8) for both males and females.](pone.0115616.g002){#pone-0115616-g002}

![SIRT5 from chromosomal to kilobase level to show the location and characteristics of two SIRT5 SNPs significantly associated with the adjusted mean age at death.\
A. SIRT5 is located on chromosome 6p23, 37,647 bp long with 8 exons.[@pone.0115616-Kent1] Blue arrows denote the three SNP genotypes within SIRT5. SNP rs2841505 is an upstream variant in a mammalian conserved region (MCR) and rs4712047 is an intron variant, not in a mammalian conserved region. SNPs denoted by a red dash are missense variants; a green dash denotes a synonymous variant. B. The gender interaction effect with rs2841505 was not significant (p = 0.55). The genotype frequency distribution did not differ between males and females (p = 0.54). C. The gender interaction effect with rs4712047 was significant (p = 0.06). The genotype frequency distribution does not differ between males and females (p = 0.47). D. Pairwise LD estimates suggest rs2841505 and rs4712047 are in low LD.](pone.0115616.g003){#pone-0115616-g003}

![AKT1 rs3803304 location and adjusted mean age at death and genotype frequency distribution stratified by gender.\
AKT1 is located on chromosome 14q32.33. [@pone.0115616-Kent1] The gender interaction effect with rs3803304 was significant (p = 0.04). There is no difference in genotype distribution between males and females (p = 0.85).](pone.0115616.g004){#pone-0115616-g004}

Sensitivity analysis demonstrated the same magnitude and direction of association for all SNPs analyzed.

Discussion {#s4}
==========

This study found the association of the *SIRT6* SNP rs107251 minor allele homozygotes (TT) with a decreased lifespan of 5.5 and 5.9 years when compared to the major allele homozygous (CC) and heterozygous (CT) genotypes, respectively, while controlling for BMI, smoking, alcohol consumption and comorbidities. However, it should be noted that only ten cohort members were in the homozygous TT genotype group. Characteristics of this SNP, and the other associated SNPs within this study, suggest they are not causal variants but are in linkage disequilibrium with a functional variant (discussed below). There is accumulating evidence of *SIRT6* impacting lifespan in mammals and now, in humans.

Sirt6-deficent mice develop aging-related abnormalities and signs of premature aging [@pone.0115616-Mostoslavsky1]. Male transgenic mice overexpressing Sirt6 were shown to have a 15% increase in median lifespan, where no increased lifespan was observed in female mice [@pone.0115616-Kanfi1]. To date, Soerensen *et al*. \[2013\], is the only other published study which has evaluated the association between *SIRT6* SNPs and lifespan, and found an association with rs107251 *(SIRT6)*. Our results also suggest rs107251 *(SIRT6)* is associated with lifespan thus confirming and extending Sorensen *et al.*\'s earlier observation to another population. Additionally, in the current study, adjusted mean age at death was calculated for each genotype allowing for the differences between the genotypes to be analyzed. To our knowledge, this is the first study to include age at death estimates and directly demonstrate the effect of a candidate genotype. Our cohort has a different genotype distribution than the HapMap --CEU population at this locus, with a lower proportion of CT and TT genotypes ([Fig. 1](#pone-0115616-g001){ref-type="fig"}). The lower TT frequency could be due to the fact that our population was at minimum 72 years of age; the results of this study suggest people with a TT genotype do not live as long. Lower TT and CT frequency may also be due to underlying population differences between the HapMap-CEU population and the 65+RHS cohort analyzed.

As shown in [Fig. 1](#pone-0115616-g001){ref-type="fig"}, *SIRT6* is located on chromosome 19p13.3; it is 8491 base pairs (bp) in length with 8 exons ranging in length from 60 bp to 838 bp [@pone.0115616-Mahlknecht1], [@pone.0115616-Kent1]. rs107251 is located 1979 bp from the 5′ end, beyond exon 4 and outside a mammalian conserved region [@pone.0115616-Kent1]. rs107251 is an intron variant, suggesting it is not causal but is in linkage disequilibrium (LD) with a functional variant within *SIRT6* or a neighboring gene. HapMap-CEU analysis of *SIRT6* identified rs107251 as capturing all of the variation within the gene. The SIRT6 protein is a nicotinamide adenine dinucleotide (NAD) dependent enzyme that has been recently shown to interact with other proteins to regulate cellular stress resistance [@pone.0115616-Simeoni1]. In male mice, Sirt6 has also been found to decrease phosphorylation in AKT and FOXO3, components of the insulin pathway, contributing to increased lifespan [@pone.0115616-Kanfi1]. Interestingly, the decrease in phosphorylation or increased lifespan was not seen in female *Sirt6*-transgenic mice. The region on chromosome 19 where *SIRT6* is located is frequently affected by chromosomal alterations in acute leukemia [@pone.0115616-Mahlknecht1].

Although much more modest than *SIRT6*, this study also found an association of variants in *SIRT3*, *SIRT5*, *FOXO3* and *SOD3* SNPs with age at death ([Table 2](#pone-0115616-t002){ref-type="table"}). The association of human lifespan and *SIRT3* has been more extensively studied compared to *SIRT6*, although with inconsistent results. *SIRT3* was found to be associated with lifespan in two studies [@pone.0115616-Rose1], [@pone.0115616-Albani1], a third did not show an association [@pone.0115616-Soerensen1], and a fourth had mixed results [@pone.0115616-Lescai1]. *SIRT5* has been associated with an increased brain molecular age [@pone.0115616-Glorioso1]. *FOXO3* has also been previously reported to be associated with lifespan [@pone.0115616-Willcox1]. Given the overwhelming body of evidence linking oxidative stress genes to aging these results are not unexpected. However, it is intriguing that studies of the same genes have yielded significant results in some studies but not others. One potential explanation for this could be that many studies only focus on a small number of candidate genes and unmeasured causal variants in weak LD with the genotyped polymorphisms are missed [@pone.0115616-Fallin1]. Additionally, the study design and model selection can substantially influence results. Many lifespan studies employ case-control designs; however, the age used to define "case" and "control" groups differs greatly among studies.

Qualitative interaction effects on final age at death were observed between gender and each of rs4758633 (*SIRT3)*, rs4712047 (*SIRT5)*, and rs3803304 (*AKT1)* ([Figs. 2](#pone-0115616-g002){ref-type="fig"}--[4](#pone-0115616-g004){ref-type="fig"}, respectively). There were differences in the distribution of risk factors for males and females ([Table 3](#pone-0115616-t003){ref-type="table"}). Gender difference in the association of genotype and lifespan has also been observed for variants in *APOE* [@pone.0115616-Seripa1], [@pone.0115616-Beydoun1] and *ADA* [@pone.0115616-Napolioni1]. Gender-specific associations have also been found for lung cancer [@pone.0115616-Dresler1], cognitive change [@pone.0115616-Beydoun2] and fat distribution [@pone.0115616-Heid1], [@pone.0115616-Zillikens1].

10.1371/journal.pone.0115616.t003

###### Characteristics of participants not analyzed *vs*. analyzed, by gender.

![](pone.0115616.t003){#pone-0115616-t003-3}

                                                Males Not Analyzed (n = 982)   Males Analyzed (n = 438)   Females Not Analyzed (n = 1499)              Females Analyzed (n = 754)                                           
  -------------------- ----------------------- ------------------------------ -------------------------- --------------------------------- -------------------------------------------------- --------- --------- --------- -------------------------------------------------
  Age at Death                  Mean                        83.8                                                       87.24                                                                    88.03               90.77   
                                Range                     66--109                                                     73--103                                                                  67--107             72--107  
                        Missing (still alive)                10                                                          2                                                                       40                  15     
                               p-value                                                                                                       **p\<0.01** [\*](#nt104){ref-type="table-fn"}                                    **p\<0.01** [\*](#nt104){ref-type="table-fn"}
  **Characteristic**        **Category**                   **N**                       **(%)**                         **N**                                    **(%)**                         **N**    **(%)**    **N**                        **(%)**
  Smoking                        No                         399                         40.6%                           189                                      43.2%                          1391      92.8%      703                          93.2%
                                 Yes                        583                         59.4%                           249                                      56.8%                           108      7.2%       51                           6.8%
                               p-value                                                                                                        p = 0.38[\*\*](#nt105){ref-type="table-fn"}                                      p = 0.73[\*\*](#nt105){ref-type="table-fn"}
  Drinking Status               Never                       185                         24.1%                           111                                      29.8%                           701      61.8%      376                          60.3%
                               Former                       120                         15.6%                           51                                       13.7%                           74       6.5%       40                           6.4%
                             Low Current                    419                         54.6%                           194                                      52.2%                           331      29.2%      192                          30.8%
                            High Current                     44                          5.7%                           16                                        4.3%                           28       2.5%       16                           2.6%
                               Missing                      214                                                         66                                                                       365                 130    
                               p-value                                                                                                        p = 0.17[\*\*](#nt105){ref-type="table-fn"}                                      p = 0.91[\*\*](#nt105){ref-type="table-fn"}
  Body Mass Index            Underweight                     26                          3.4%                            7                                        1.8%                           83       6.6%       21                           3.0%
                               Normal                       339                         43.7%                           146                                      37.0%                           651      52.0%      336                          48.8%
                             Overweight                     343                         44.2%                           197                                      49.9%                           355      28.4%      243                          35.3%
                                Obese                        68                          8.8%                           45                                       11.4%                           162      12.9%      89                           12.9%
                               missing                      206                                                         43                                                                       248                 65     
                               p-value                                                                                                      **p = 0.03** [\*\*](#nt105){ref-type="table-fn"}                                 **p\<0.01** [\*\*](#nt105){ref-type="table-fn"}
  Comorbidity Count               0                         408                         41.9%                           205                                      47.1%                           591      39.6%      346                          46.2%
                                  1                         410                         42.1%                           167                                      38.4%                           667      44.7%      335                          44.7%
                                 \>1                        156                         16.0%                           63                                       14.5%                           233      15.6%      68                           9.1%
                               Missing                       8                                                           3                                                                        8                   5     
                               p-value                                                                                                        p = 0.19[\*\*](#nt105){ref-type="table-fn"}                                    **p\<0.01** [\*\*](#nt105){ref-type="table-fn"}
  Exercise                  Highly Active                   340                         34.6%                           139                                      31.7%                           374      24.9%      157                          20.8%
                              Moderate                      356                         36.3%                           190                                      43.4%                           573      38.2%      364                          48.3%
                              Inactive                      286                         29.1%                           109                                      24.9%                           552      36.8%      233                          30.9%
                               p-value                                                                                                      **p\<0.01** [\*\*](#nt105){ref-type="table-fn"}                                  **p\<0.01** [\*\*](#nt105){ref-type="table-fn"}

\*Student\'s t-test p-value compares the mean age at death for participants not analyzed *vs*. analyzed by gender.

\*\*Chi-square p-value compares distribution within categories for participants not analyzed with participants analyzed, by gender.

Differences in life-span between and males and females exist in various regions of the world, with females living a mean of 4.2 years longer than males; this is projected to increase to 4.8 years by the year 2050 [@pone.0115616-Eskes1], [@pone.0115616-Austad1]. Theories for this difference include females having two X-chromosomes, the suppressing effects of estrogens upon aging-related cell senescence and the favorable cardiovascular effects of hormonal fluctuations in females during their reproductive period [@pone.0115616-Eskes1]. A study in rats showed estrogens were responsible for lower mitochondrial free-radical production observed in females compared to males [@pone.0115616-Vina1]. Though women in this study are post-menopausal, estrogen may have decreased the oxidative-stress burden throughout life contributing to the increased lifespan. For rs4758633 (*SIRT3)*, the gender-specific genotype frequency distributions were significantly different (p\<0.01). Females in the 65+RHS had a higher proportion of the AA genotype than males. This genotype was associated with a greater lifespan in females but not males and could explain a small proportion of the mean difference in lifespan for females and males.

In [Figs. 2](#pone-0115616-g002){ref-type="fig"} and [3](#pone-0115616-g003){ref-type="fig"}, both *SIRT3* and *SIRT5* had one SNP which was significant for males and females combined (rs511744 *SIRT3* and rs2841505 *SIRT5*) but another SNP which showed a significant gender interaction effect (rs4758633 *SIRT3* and rs4712047 *SIRT5*). rs2841505 is a sequence variant located 5′ of *SIRT5*, while the other three SNPs are intron variants. This suggests these four SNPs are not causal but are in LD with a functional variation of the respective, or neighboring, gene. It also suggests estrogen or another factor could be causing the gene or its proteins to act differently in males and females. This may be another contributing factor to inconsistent results among studies (when gender-specific effects are not considered) and highlights the importance of entire genetic coverage and investigation of effect modification due to gender in association studies.

Caution must be taken with these results due to several limitations. First, this study population was a relatively small sample. Only ten cohort members had the homozygous minor allele genotype for rs107251, which demonstrated the greatest impact on lifespan. Second, these analyses were exploratory and a p-value of 0.1 was used to evaluate interaction effects. Third, there may be residual confounding in smoking and other variables. Due to small numbers of smokers only two categories (ever vs. never) were used. Fourth, the minimum age at the time of enrollment into the study in 1982--83 was 65 and blood wasn\'t collected until the 6^th^ interview during 1987--89. Selective pressures that influenced their mortality, such as caloric restriction of the Great Depression and absence of vaccination, are different than today and may influence results [@pone.0115616-BrooksWilson1]. The effects of caloric restriction may be minimized since BMI was controlled for, although information regarding caloric restriction is not likely captured entirely by BMI. It should be noted that the range of ages in this study might be ideal for studying genetic effects and aging. The GenomeEUtwin project, including more than 20,000 Nordic twins, saw that genetic effects on lifespans were minimal prior to 60 years of age, but genetic effects on lifespan after age 60 were significant and constant to increasing with advancing age [@pone.0115616-Murabito1]. Fifth, these SNPs are not causal but are in LD with functional variants. Further investigation is needed to identify the variation which is impacting age at death. Finally, all exposure information was self-reported from the baseline interview. However, this information has been shown to be relatively accurate [@pone.0115616-Cerhan1], [@pone.0115616-Avendano1], [@pone.0115616-Purser1].

In addition to potentially being an ideal age group this study has other strengths. Death dates were available for an overwhelming majority of this population. Although self-reported, the baseline survey provided information and aging-related risk factors that could be controlled for. In genetic testing, an environmental factor itself is of no direct interest but can be an important component in controlling for potential confounding [@pone.0115616-Yi1]. Positive false discovery rates were controlled when evaluating the 45 SNPs where the gender × SNP interaction effect was not significant (p\>0.1). Utilizing a multivariable linear model allowed for evaluation of the adjusted mean age at death for each genotype.

In conclusion, our data suggest associations between lifespan and several sirtuin and oxidative stress gene SNPs, most notable in *SIRT6*. Qualitative effect modification was significant for variants in *SIRT3*, *SIRT5* and *AKT1*. These findings show the importance of utilizing information provided through animal models in candidate genetic studies. Furthermore, our data suggest that effects of gender and aging-related risk factors should be controlled for in lifespan studies and that stratification by gender may reveal effect modification. This study was exploratory and replication of these findings in other human populations is needed.
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